BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tufariello JM, Chan J, Flynn JL. Latent tuberculosis: mechanisms of host and bacillus that contribute to persistent infection. Lancet Infect Dis 2003;3:578-90. [PMID: 12954564 DOI: 10.1016/s1473-3099(03)00741-2] [Cited by in Crossref: 241] [Cited by in F6Publishing: 115] [Article Influence: 12.7] [Reference Citation Analysis]
Number Citing Articles
1 Raghuvanshi S, Sharma P, Singh S, Van Kaer L, Das G. Mycobacterium tuberculosis evades host immunity by recruiting mesenchymal stem cells. Proc Natl Acad Sci U S A 2010;107:21653-8. [PMID: 21135221 DOI: 10.1073/pnas.1007967107] [Cited by in Crossref: 75] [Cited by in F6Publishing: 66] [Article Influence: 6.3] [Reference Citation Analysis]
2 Ribeiro GM, Matsumoto CK, Real F, Teixeira D, Duarte RS, Mortara RA, Leão SC, de Souza Carvalho-Wodarz C. Increased survival and proliferation of the epidemic strain Mycobacterium abscessus subsp. massiliense CRM0019 in alveolar epithelial cells. BMC Microbiol 2017;17:195. [PMID: 28903728 DOI: 10.1186/s12866-017-1102-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
3 Cuccu B, Freer G, Genovesi A, Garzelli C, Rindi L. Identification of a human immunodominant T-cell epitope of mycobacterium tuberculosis antigen PPE44. BMC Microbiol 2011;11:167. [PMID: 21787411 DOI: 10.1186/1471-2180-11-167] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
4 Tallman KR, Levine SR, Beatty KE. Profiling Esterases in Mycobacterium tuberculosis Using Far-Red Fluorogenic Substrates. ACS Chem Biol 2016;11:1810-5. [PMID: 27177211 DOI: 10.1021/acschembio.6b00233] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.5] [Reference Citation Analysis]
5 Denholm JT, McBryde ES. The use of anti-tuberculosis therapy for latent TB infection. Infect Drug Resist 2010;3:63-72. [PMID: 21694895 DOI: 10.2147/idr.s8994] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
6 Eishi Y. Etiologic aspect of sarcoidosis as an allergic endogenous infection caused by Propionibacterium acnes. Biomed Res Int 2013;2013:935289. [PMID: 23844371 DOI: 10.1155/2013/935289] [Cited by in Crossref: 56] [Cited by in F6Publishing: 48] [Article Influence: 6.2] [Reference Citation Analysis]
7 Orme IM. Development of new vaccines and drugs for TB: limitations and potential strategic errors. Future Microbiol 2011;6:161-77. [PMID: 21366417 DOI: 10.2217/fmb.10.168] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 4.0] [Reference Citation Analysis]
8 Tufariello JM, Mi K, Xu J, Manabe YC, Kesavan AK, Drumm J, Tanaka K, Jacobs WR Jr, Chan J. Deletion of the Mycobacterium tuberculosis resuscitation-promoting factor Rv1009 gene results in delayed reactivation from chronic tuberculosis. Infect Immun 2006;74:2985-95. [PMID: 16622237 DOI: 10.1128/IAI.74.5.2985-2995.2006] [Cited by in Crossref: 93] [Cited by in F6Publishing: 44] [Article Influence: 5.8] [Reference Citation Analysis]
9 Vasconcelos-Santos DV, Zierhut M, Rao NA. Strengths and weaknesses of diagnostic tools for tuberculous uveitis. Ocul Immunol Inflamm 2009;17:351-5. [PMID: 19831571 DOI: 10.3109/09273940903168688] [Cited by in Crossref: 59] [Cited by in F6Publishing: 50] [Article Influence: 4.9] [Reference Citation Analysis]
10 Hisert KB, Kirksey MA, Gomez JE, Sousa AO, Cox JS, Jacobs WR Jr, Nathan CF, McKinney JD. Identification of Mycobacterium tuberculosis counterimmune (cim) mutants in immunodeficient mice by differential screening. Infect Immun 2004;72:5315-21. [PMID: 15322028 DOI: 10.1128/IAI.72.9.5315-5321.2004] [Cited by in Crossref: 40] [Cited by in F6Publishing: 16] [Article Influence: 2.2] [Reference Citation Analysis]
11 Kulkarni R, Deshpande A, Saxena R, Saxena K. A study of serum malondialdehyde and cytokine in tuberculosis patients. J Clin Diagn Res. 2013;7:2140-2142. [PMID: 24298458 DOI: 10.7860/jcdr/2013/5736.3452] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
12 Kozarov E. Bacterial invasion of vascular cell types: vascular infectology and atherogenesis. Future Cardiol. 2012;8:123-138. [PMID: 22185451 DOI: 10.2217/fca.11.75] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 3.3] [Reference Citation Analysis]
13 Houghton J, Townsend C, Williams AR, Rodgers A, Rand L, Walker KB, Böttger EC, Springer B, Davis EO. Important role for Mycobacterium tuberculosis UvrD1 in pathogenesis and persistence apart from its function in nucleotide excision repair. J Bacteriol 2012;194:2916-23. [PMID: 22467787 DOI: 10.1128/JB.06654-11] [Cited by in Crossref: 20] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
14 Hokey DA, Wachholder R, Darrah PA, Bolton DL, Barouch DH, Hill K, Dheenadhayalan V, Schwander S, Godin CS, Douoguih M, Pau MG, Seder RA, Roederer M, Sadoff JC, Sizemore D. A nonhuman primate toxicology and immunogenicity study evaluating aerosol delivery of AERAS-402/Ad35 vaccine: Evidence for transient t cell responses in peripheral blood and robust sustained responses in the lungs. Hum Vaccin Immunother 2014;10:2199-210. [PMID: 25424923 DOI: 10.4161/hv.29108] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.9] [Reference Citation Analysis]
15 Francisco-Cruz A, Mata-Espinosa D, Estrada-Parra S, Xing Z, Hernández-Pando R. Immunotherapeutic effects of recombinant adenovirus encoding granulocyte-macrophage colony-stimulating factor in experimental pulmonary tuberculosis. Clin Exp Immunol. 2013;171:283-297. [PMID: 23379435 DOI: 10.1111/cei.12015] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
16 Carlos D, Fremond C, Samarina A, Vasseur V, Maillet I, Ramos SG, Erard F, Quesniaux V, Ohtsu H, Silva CL, Faccioli LH, Ryffel B. Histamine plays an essential regulatory role in lung inflammation and protective immunity in the acute phase of Mycobacterium tuberculosis infection. Infect Immun 2009;77:5359-68. [PMID: 19822651 DOI: 10.1128/IAI.01497-08] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
17 Graves AJ, Hokey DA. Tuberculosis vaccine development: Shifting focus amid increasing development challenges. Hum Vaccin Immunother 2015;11:1910-6. [PMID: 26125249 DOI: 10.1080/21645515.2015.1040955] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
18 Fraisse P. Diagnostic des infections tuberculeuses latentes (sujets sains, sujets immunodéprimés ou amenés à l’être). Revue des Maladies Respiratoires 2012;29:277-318. [DOI: 10.1016/j.rmr.2011.05.019] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
19 Klinkenberg LG, Sutherland LA, Bishai WR, Karakousis PC. Metronidazole lacks activity against Mycobacterium tuberculosis in an in vivo hypoxic granuloma model of latency. J Infect Dis 2008;198:275-83. [PMID: 18491971 DOI: 10.1086/589515] [Cited by in Crossref: 59] [Cited by in F6Publishing: 58] [Article Influence: 4.2] [Reference Citation Analysis]
20 Hodgson K, Morris J, Bridson T, Govan B, Rush C, Ketheesan N. Immunological mechanisms contributing to the double burden of diabetes and intracellular bacterial infections. Immunology. 2015;144:171-185. [PMID: 25262977 DOI: 10.1111/imm.12394] [Cited by in Crossref: 153] [Cited by in F6Publishing: 150] [Article Influence: 21.9] [Reference Citation Analysis]
21 Chen Y, Yang F, Sun Z, Wang Q, Mi K, Deng H. Proteomic Analysis of Drug-Resistant Mycobacteria: Co-Evolution of Copper and INH Resistance. PLoS One 2015;10:e0127788. [PMID: 26035302 DOI: 10.1371/journal.pone.0127788] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
22 HaileMariam M, Yu Y, Singh H, Teklu T, Wondale B, Worku A, Zewude A, Mounaud S, Tsitrin T, Legesse M, Gobena A, Pieper R. Protein and Microbial Biomarkers in Sputum Discern Acute and Latent Tuberculosis in Investigation of Pastoral Ethiopian Cohort. Front Cell Infect Microbiol 2021;11:595554. [PMID: 34150670 DOI: 10.3389/fcimb.2021.595554] [Reference Citation Analysis]
23 Lanoix JP, Betoudji F, Nuermberger E. Novel regimens identified in mice for treatment of latent tuberculosis infection in contacts of patients with multidrug-resistant tuberculosis. Antimicrob Agents Chemother 2014;58:2316-21. [PMID: 24492372 DOI: 10.1128/AAC.02658-13] [Cited by in Crossref: 23] [Cited by in F6Publishing: 10] [Article Influence: 2.9] [Reference Citation Analysis]
24 Ritter K, Sodenkamp JC, Hölscher A, Behrends J, Hölscher C. IL-6 is not Absolutely Essential for the Development of a TH17 Immune Response after an Aerosol Infection with Mycobacterium Tuberculosis H37rv. Cells 2020;10:E9. [PMID: 33375150 DOI: 10.3390/cells10010009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Shannon JG, Heinzen RA. Adaptive immunity to the obligate intracellular pathogen Coxiella burnetii. Immunol Res 2009;43:138-48. [PMID: 18813881 DOI: 10.1007/s12026-008-8059-4] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 3.4] [Reference Citation Analysis]
26 Zhang X, Xie Q, Ye Z, Li Y, Che Z, Huang M, Zeng J. Mesenchymal Stem Cells and Tuberculosis: Clinical Challenges and Opportunities. Front Immunol 2021;12:695278. [PMID: 34367155 DOI: 10.3389/fimmu.2021.695278] [Reference Citation Analysis]
27 Fitzgerald LE, Abendaño N, Juste RA, Alonso-Hearn M. Three-dimensional in vitro models of granuloma to study bacteria-host interactions, drug-susceptibility, and resuscitation of dormant mycobacteria. Biomed Res Int 2014;2014:623856. [PMID: 24967387 DOI: 10.1155/2014/623856] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
28 Daniel J, Deb C, Dubey VS, Sirakova TD, Abomoelak B, Morbidoni HR, Kolattukudy PE. Induction of a novel class of diacylglycerol acyltransferases and triacylglycerol accumulation in Mycobacterium tuberculosis as it goes into a dormancy-like state in culture. J Bacteriol 2004;186:5017-30. [PMID: 15262939 DOI: 10.1128/JB.186.15.5017-5030.2004] [Cited by in Crossref: 263] [Cited by in F6Publishing: 145] [Article Influence: 14.6] [Reference Citation Analysis]
29 Ojha AK, Jacobs WR Jr, Hatfull GF. Genetic dissection of mycobacterial biofilms. Methods Mol Biol 2015;1285:215-26. [PMID: 25779318 DOI: 10.1007/978-1-4939-2450-9_12] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
30 Mustafa T, Brokstad KA, Mfinanga SG, Wiker HG. Multiplex Analysis of Pro- or Anti-Inflammatory Serum Cytokines and Chemokines in relation to Gender and Age among Tanzanian Tuberculous Lymphadenitis Patients. Tuberc Res Treat 2015;2015:561490. [PMID: 26060581 DOI: 10.1155/2015/561490] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
31 Khan AU, Khanduri S, Tarin Z, Abbas SZ, Husain M, Singh A, Yadav P, Jain S. Dual-Energy Computed Tomography Lung in patients of Pulmonary Tuberculosis. J Clin Imaging Sci 2020;10:39. [PMID: 32754374 DOI: 10.25259/JCIS_78_2020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
32 Peyron P, Vaubourgeix J, Poquet Y, Levillain F, Botanch C, Bardou F, Daffé M, Emile JF, Marchou B, Cardona PJ, de Chastellier C, Altare F. Foamy macrophages from tuberculous patients' granulomas constitute a nutrient-rich reservoir for M. tuberculosis persistence. PLoS Pathog 2008;4:e1000204. [PMID: 19002241 DOI: 10.1371/journal.ppat.1000204] [Cited by in Crossref: 434] [Cited by in F6Publishing: 411] [Article Influence: 31.0] [Reference Citation Analysis]
33 Rodríguez JE, Ramírez AS, Salas LP, Helguera-Repetto C, Gonzalez-y-Merchand J, Soto CY, Hernández-Pando R. Transcription of genes involved in sulfolipid and polyacyltrehalose biosynthesis of Mycobacterium tuberculosis in experimental latent tuberculosis infection. PLoS One 2013;8:e58378. [PMID: 23472191 DOI: 10.1371/journal.pone.0058378] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
34 Mills HL, Cohen T, Colijn C. Community-wide isoniazid preventive therapy drives drug-resistant tuberculosis: a model-based analysis. Sci Transl Med 2013;5:180ra49. [PMID: 23576815 DOI: 10.1126/scitranslmed.3005260] [Cited by in Crossref: 17] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]
35 Connell TG, Curtis N, Ranganathan SC, Buttery JP. Performance of a whole blood interferon gamma assay for detecting latent infection with Mycobacterium tuberculosis in children. Thorax 2006;61:616-20. [PMID: 16601088 DOI: 10.1136/thx.2005.048033] [Cited by in Crossref: 122] [Cited by in F6Publishing: 111] [Article Influence: 7.6] [Reference Citation Analysis]
36 Fisher-Hoch SP, Whitney E, McCormick JB, Crespo G, Smith B, Rahbar MH, Restrepo BI. Type 2 diabetes and multidrug-resistant tuberculosis. Scand J Infect Dis 2008;40:888-93. [PMID: 18728934 DOI: 10.1080/00365540802342372] [Cited by in Crossref: 64] [Cited by in F6Publishing: 64] [Article Influence: 4.9] [Reference Citation Analysis]
37 Salindri AD, Auld SC, Schechter MC, Gandhi NR, Magee MJ. Negative tuberculin skin test result predicts all-cause mortality among tuberculosis patients with HIV and diabetes comorbidity. Ann Epidemiol 2019;33:72-78.e4. [PMID: 30954339 DOI: 10.1016/j.annepidem.2019.02.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
38 Darwich L, Coma G, Peña R, Bellido R, Blanco EJ, Este JA, Borras FE, Clotet B, Ruiz L, Rosell A, Andreo F, Parkhouse RM, Bofill M. Secretion of interferon-gamma by human macrophages demonstrated at the single-cell level after costimulation with interleukin (IL)-12 plus IL-18. Immunology 2009;126:386-93. [PMID: 18759749 DOI: 10.1111/j.1365-2567.2008.02905.x] [Cited by in Crossref: 97] [Cited by in F6Publishing: 104] [Article Influence: 6.9] [Reference Citation Analysis]
39 Lichtner M, Rossi R, Mengoni F, Vignoli S, Colacchia B, Massetti AP, Kamga I, Hosmalin A, Vullo V, Mastroianni CM. Circulating dendritic cells and interferon-alpha production in patients with tuberculosis: correlation with clinical outcome and treatment response. Clin Exp Immunol 2006;143:329-37. [PMID: 16412058 DOI: 10.1111/j.1365-2249.2005.02994.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 2.3] [Reference Citation Analysis]
40 Harris J, Keane J. How tumour necrosis factor blockers interfere with tuberculosis immunity. Clin Exp Immunol 2010;161:1-9. [PMID: 20491796 DOI: 10.1111/j.1365-2249.2010.04146.x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 111] [Article Influence: 4.8] [Reference Citation Analysis]
41 Howell AK, McCann CM, Wickstead F, Williams DJL. Co-infection of cattle with Fasciola hepatica or F. gigantica and Mycobacterium bovis: A systematic review. PLoS One 2019;14:e0226300. [PMID: 31887151 DOI: 10.1371/journal.pone.0226300] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
42 Lagrange PH, Herrmann JL. Diagnosing latent tuberculosis infection in the HIV era. Open Respir Med J 2008;2:52-9. [PMID: 19343092 DOI: 10.2174/1874306400802010052] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
43 Zhang J, Zheng L, Zhu D, An H, Yang Y, Liang Y, Zhao W, Ding W, Wu X. Polymorphisms in the interleukin 18 receptor 1 gene and tuberculosis susceptibility among Chinese. PLoS One 2014;9:e110734. [PMID: 25360588 DOI: 10.1371/journal.pone.0110734] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
44 Mehra S, Golden NA, Stuckey K, Didier PJ, Doyle LA, Russell-Lodrigue KE, Sugimoto C, Hasegawa A, Sivasubramani SK, Roy CJ, Alvarez X, Kuroda MJ, Blanchard JL, Lackner AA, Kaushal D. The Mycobacterium tuberculosis stress response factor SigH is required for bacterial burden as well as immunopathology in primate lungs. J Infect Dis 2012;205:1203-13. [PMID: 22402035 DOI: 10.1093/infdis/jis102] [Cited by in Crossref: 54] [Cited by in F6Publishing: 51] [Article Influence: 5.4] [Reference Citation Analysis]
45 Tallman KR, Levine SR, Beatty KE. Small-Molecule Probes Reveal Esterases with Persistent Activity in Dormant and Reactivating Mycobacterium tuberculosis. ACS Infect Dis 2016;2:936-44. [PMID: 27690385 DOI: 10.1021/acsinfecdis.6b00135] [Cited by in Crossref: 38] [Cited by in F6Publishing: 29] [Article Influence: 6.3] [Reference Citation Analysis]
46 Purdie AC, Plain KM, Begg DJ, de Silva K, Whittington RJ. Gene expression profiles during subclinical Mycobacterium avium subspecies paratuberculosis infection in sheep can predict disease outcome. Sci Rep 2019;9:8245. [PMID: 31160677 DOI: 10.1038/s41598-019-44670-w] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
47 Meghari S, Bechah Y, Capo C, Lepidi H, Raoult D, Murray PJ, Mege JL. Persistent Coxiella burnetii infection in mice overexpressing IL-10: an efficient model for chronic Q fever pathogenesis. PLoS Pathog 2008;4:e23. [PMID: 18248094 DOI: 10.1371/journal.ppat.0040023] [Cited by in Crossref: 66] [Cited by in F6Publishing: 59] [Article Influence: 4.7] [Reference Citation Analysis]
48 Kapoor N, Pawar S, Sirakova TD, Deb C, Warren WL, Kolattukudy PE. Human granuloma in vitro model, for TB dormancy and resuscitation. PLoS One 2013;8:e53657. [PMID: 23308269 DOI: 10.1371/journal.pone.0053657] [Cited by in Crossref: 112] [Cited by in F6Publishing: 103] [Article Influence: 12.4] [Reference Citation Analysis]
49 Pennisi M, Russo G, Sgroi G, Bonaccorso A, Parasiliti Palumbo GA, Fichera E, Mitra DK, Walker KB, Cardona PJ, Amat M, Viceconti M, Pappalardo F. Predicting the artificial immunity induced by RUTI® vaccine against tuberculosis using universal immune system simulator (UISS). BMC Bioinformatics 2019;20:504. [PMID: 31822272 DOI: 10.1186/s12859-019-3045-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
50 Ozkan E, Yaman H, Cakir E, Deniz O, Oztosun M, Gumus S, Akgul EO, Agilli M, Cayci T, Kurt YG, Aydin I, Arslan Y, Ilhan N, Ilhan N, Erbil MK. Plasma melatonin and urinary 6-hydroxymelatonin levels in patients with pulmonary tuberculosis. Inflammation 2012;35:1429-34. [PMID: 22430231 DOI: 10.1007/s10753-012-9456-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
51 Joao I, Bujdáková H, Jordao L. Opportunist Coinfections by Nontuberculous Mycobacteria and Fungi in Immunocompromised Patients. Antibiotics (Basel) 2020;9:E771. [PMID: 33147819 DOI: 10.3390/antibiotics9110771] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
52 Rao V, Gao F, Chen B, Jacobs WR Jr, Glickman MS. Trans-cyclopropanation of mycolic acids on trehalose dimycolate suppresses Mycobacterium tuberculosis -induced inflammation and virulence. J Clin Invest 2006;116:1660-7. [PMID: 16741578 DOI: 10.1172/JCI27335] [Cited by in Crossref: 146] [Cited by in F6Publishing: 70] [Article Influence: 9.1] [Reference Citation Analysis]
53 Savage KT, Flood KS, Porter ML, Kimball AB. TNF-α inhibitors in the treatment of hidradenitis suppurativa. Ther Adv Chronic Dis 2019;10:2040622319851640. [PMID: 31191873 DOI: 10.1177/2040622319851640] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
54 Abdalla AE, Li Q, Xie L, Xie J. Biology of IL-27 and its role in the host immunity against Mycobacterium tuberculosis. Int J Biol Sci 2015;11:168-75. [PMID: 25561899 DOI: 10.7150/ijbs.10464] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
55 Rossi I, Buttini F, Sonvico F, Affaticati F, Martinelli F, Annunziato G, Machado D, Viveiros M, Pieroni M, Bettini R. Sodium Hyaluronate Nanocomposite Respirable Microparticles to Tackle Antibiotic Resistance with Potential Application in Treatment of Mycobacterial Pulmonary Infections. Pharmaceutics 2019;11:E203. [PMID: 31052403 DOI: 10.3390/pharmaceutics11050203] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
56 Hokey DA, Ginsberg A. The current state of tuberculosis vaccines. Hum Vaccin Immunother 2013;9:2142-6. [PMID: 23792698 DOI: 10.4161/hv.25427] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
57 Ralph AP, Yeo TW, Salome CM, Waramori G, Pontororing GJ, Kenangalem E, Sandjaja, Tjitra E, Lumb R, Maguire GP, Price RN, Chatfield MD, Kelly PM, Anstey NM. Impaired pulmonary nitric oxide bioavailability in pulmonary tuberculosis: association with disease severity and delayed mycobacterial clearance with treatment. J Infect Dis 2013;208:616-26. [PMID: 23737604 DOI: 10.1093/infdis/jit248] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
58 Hijikata M, Shojima J, Matsushita I, Tokunaga K, Ohashi J, Hang NT, Horie T, Sakurada S, Hoang NP, Thuong PH, Lien LT, Keicho N. Association of IFNGR2 gene polymorphisms with pulmonary tuberculosis among the Vietnamese. Hum Genet 2012;131:675-82. [PMID: 22057826 DOI: 10.1007/s00439-011-1112-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
59 Ahmad S. New approaches in the diagnosis and treatment of latent tuberculosis infection. Respir Res 2010;11:169. [PMID: 21126375 DOI: 10.1186/1465-9921-11-169] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 3.3] [Reference Citation Analysis]
60 Drobniewski F, Balabanova Y, Zakamova E, Nikolayevskyy V, Fedorin I. Rates of latent tuberculosis in health care staff in Russia. PLoS Med 2007;4:e55. [PMID: 17298167 DOI: 10.1371/journal.pmed.0040055] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 2.4] [Reference Citation Analysis]
61 Sahiratmadja E, Alisjahbana B, de Boer T, Adnan I, Maya A, Danusantoso H, Nelwan RH, Marzuki S, van der Meer JW, van Crevel R, van de Vosse E, Ottenhoff TH. Dynamic changes in pro- and anti-inflammatory cytokine profiles and gamma interferon receptor signaling integrity correlate with tuberculosis disease activity and response to curative treatment. Infect Immun 2007;75:820-9. [PMID: 17145950 DOI: 10.1128/IAI.00602-06] [Cited by in Crossref: 123] [Cited by in F6Publishing: 61] [Article Influence: 7.7] [Reference Citation Analysis]
62 Massy R, Herbort CP. Contribution of Dual Fluorescein and Indocyanine Green Angiography to the Appraisal of Presumed Tuberculous Chorioretinitis in a Non-endemic Area. J Ophthalmic Vis Res 2017;12:30-8. [PMID: 28299004 DOI: 10.4103/2008-322X.200157] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
63 Meng QL, Liu F, Yang XY, Liu XM, Zhang X, Zhang C, Zhang ZD. Identification of latent tuberculosis infection-related microRNAs in human U937 macrophages expressing Mycobacterium tuberculosis Hsp16.3. BMC Microbiol 2014;14:37. [PMID: 24521422 DOI: 10.1186/1471-2180-14-37] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 4.3] [Reference Citation Analysis]
64 Bhatt K, Salgame P. Host innate immune response to Mycobacterium tuberculosis. J Clin Immunol 2007;27:347-62. [PMID: 17364232 DOI: 10.1007/s10875-007-9084-0] [Cited by in Crossref: 135] [Cited by in F6Publishing: 128] [Article Influence: 9.0] [Reference Citation Analysis]
65 Marín ND, París SC, Rojas M, García LF. Reduced frequency of memory T cells and increased Th17 responses in patients with active tuberculosis. Clin Vaccine Immunol 2012;19:1667-76. [PMID: 22914361 DOI: 10.1128/CVI.00390-12] [Cited by in Crossref: 30] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
66 Park JH, Shim D, Kim KES, Lee W, Shin SJ. Understanding Metabolic Regulation Between Host and Pathogens: New Opportunities for the Development of Improved Therapeutic Strategies Against Mycobacterium tuberculosis Infection. Front Cell Infect Microbiol 2021;11:635335. [PMID: 33796480 DOI: 10.3389/fcimb.2021.635335] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
67 Lu L, Wei R, Bhakta S, Waddell SJ, Boix E. Weighted Gene Co-Expression Network Analysis Identifies Key Modules and Hub Genes Associated with Mycobacterial Infection of Human Macrophages. Antibiotics (Basel) 2021;10:97. [PMID: 33498280 DOI: 10.3390/antibiotics10020097] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
68 Sharma T, Grover S, Arora N, P M, Ehtesham NZ, Hasnain SE. PGRS Domain of Rv0297 of Mycobacterium tuberculosis Is Involved in Modulation of Macrophage Functions to Favor Bacterial Persistence. Front Cell Infect Microbiol 2020;10:451. [PMID: 33042856 DOI: 10.3389/fcimb.2020.00451] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
69 Chiu BC, Stolberg VR, Freeman CM, Chensue SW. Mononuclear phagocyte-derived interleukin-10 suppresses the innate pulmonary granuloma cytokine response in aged mice. Am J Pathol 2007;171:829-37. [PMID: 17631521 DOI: 10.2353/ajpath.2007.061122] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
70 Machowski EE, Senzani S, Ealand C, Kana BD. Comparative genomics for mycobacterial peptidoglycan remodelling enzymes reveals extensive genetic multiplicity. BMC Microbiol 2014;14:75. [PMID: 24661741 DOI: 10.1186/1471-2180-14-75] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 4.5] [Reference Citation Analysis]
71 Ramirez-Alejo N, Santos-Argumedo L. Innate defects of the IL-12/IFN-γ axis in susceptibility to infections by mycobacteria and salmonella. J Interferon Cytokine Res 2014;34:307-17. [PMID: 24359575 DOI: 10.1089/jir.2013.0050] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 4.6] [Reference Citation Analysis]
72 Naik S, Alexander M, Kumar P, Kulkarni V, Deshpande P, Yadana S, Leu CS, Araújo-Pereira M, Andrade BB, Bhosale R, Babu S, Gupta A, Mathad JS, Shivakoti R. Systemic Inflammation in Pregnant Women With Latent Tuberculosis Infection. Front Immunol 2020;11:587617. [PMID: 33584652 DOI: 10.3389/fimmu.2020.587617] [Reference Citation Analysis]
73 Zhang Y, Yew WW, Barer MR. Targeting persisters for tuberculosis control. Antimicrob Agents Chemother. 2012;56:2223-2230. [PMID: 22391538 DOI: 10.1128/aac.06288-11] [Cited by in Crossref: 156] [Cited by in F6Publishing: 94] [Article Influence: 15.6] [Reference Citation Analysis]
74 Morel PA, Ta'asan S, Morel BF, Kirschner DE, Flynn JL. New insights into mathematical modeling of the immune system. Immunol Res 2006;36:157-65. [PMID: 17337776 DOI: 10.1385/IR:36:1:157] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
75 Abhishek S, Saikia UN, Gupta A, Bansal R, Gupta V, Singh N, Laal S, Verma I. Transcriptional Profile of Mycobacterium tuberculosis in an in vitro Model of Intraocular Tuberculosis. Front Cell Infect Microbiol 2018;8:330. [PMID: 30333960 DOI: 10.3389/fcimb.2018.00330] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
76 Chiacchio T, Petruccioli E, Vanini V, Butera O, Cuzzi G, Petrone L, Matteucci G, Lauria FN, Franken KL, Girardi E, Ottenhoff TH, Goletti D. Higher frequency of T-cell response to M. tuberculosis latency antigen Rv2628 at the site of active tuberculosis disease than in peripheral blood. PLoS One 2011;6:e27539. [PMID: 22102905 DOI: 10.1371/journal.pone.0027539] [Cited by in Crossref: 45] [Cited by in F6Publishing: 44] [Article Influence: 4.1] [Reference Citation Analysis]
77 Keren I, Shah D, Spoering A, Kaldalu N, Lewis K. Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli. J Bacteriol. 2004;186:8172-8180. [PMID: 15576765 DOI: 10.1128/jb.186.24.8172-8180.2004] [Cited by in Crossref: 598] [Cited by in F6Publishing: 317] [Article Influence: 35.2] [Reference Citation Analysis]
78 Hossain MM, Norazmi MN. Pattern recognition receptors and cytokines in Mycobacterium tuberculosis infection--the double-edged sword? Biomed Res Int. 2013;2013:179174. [PMID: 24350246 DOI: 10.1155/2013/179174] [Cited by in Crossref: 65] [Cited by in F6Publishing: 62] [Article Influence: 7.2] [Reference Citation Analysis]
79 Mezouar S, Diarra I, Roudier J, Desnues B, Mege JL. Tumor Necrosis Factor-Alpha Antagonist Interferes With the Formation of Granulomatous Multinucleated Giant Cells: New Insights Into Mycobacterium tuberculosis Infection. Front Immunol 2019;10:1947. [PMID: 31475008 DOI: 10.3389/fimmu.2019.01947] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
80 Kashino SS, Vallerskog T, Martens G, Troudt J, Keyser A, Taylor J, Izzo A, Kornfeld H, Campos-Neto A. Initiation of acquired immunity in the lungs of mice lacking lymph nodes after infection with aerosolized Mycobacterium tuberculosis. Am J Pathol 2010;176:198-204. [PMID: 20008132 DOI: 10.2353/ajpath.2010.090446] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
81 Sargentini V, Mariotti S, Carrara S, Gagliardi MC, Teloni R, Goletti D, Nisini R. Cytometric detection of antigen-specific IFN-gamma/IL-2 secreting cells in the diagnosis of tuberculosis. BMC Infect Dis 2009;9:99. [PMID: 19549330 DOI: 10.1186/1471-2334-9-99] [Cited by in Crossref: 61] [Cited by in F6Publishing: 58] [Article Influence: 4.7] [Reference Citation Analysis]
82 Dawany N, Showe LC, Kossenkov AV, Chang C, Ive P, Conradie F, Stevens W, Sanne I, Azzoni L, Montaner LJ. Identification of a 251 gene expression signature that can accurately detect M. tuberculosis in patients with and without HIV co-infection. PLoS One 2014;9:e89925. [PMID: 24587128 DOI: 10.1371/journal.pone.0089925] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
83 Jordao L, Vieira OV. Tuberculosis: new aspects of an old disease. Int J Cell Biol 2011;2011:403623. [PMID: 21760796 DOI: 10.1155/2011/403623] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
84 Güthlein C, Wanner RM, Sander P, Böttger EC, Springer B. A mycobacterial smc null mutant is proficient in DNA repair and long-term survival. J Bacteriol 2008;190:452-6. [PMID: 17981972 DOI: 10.1128/JB.01315-07] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
85 Ruan Q, Zhang S, Ai J, Shao L, Zhang W. Screening of latent tuberculosis infection by interferon-γ release assays in rheumatic patients: a systemic review and meta-analysis. Clin Rheumatol 2016;35:417-25. [PMID: 25376466 DOI: 10.1007/s10067-014-2817-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
86 Hett EC, Rubin EJ. Bacterial growth and cell division: a mycobacterial perspective. Microbiol Mol Biol Rev 2008;72:126-56, table of contents. [PMID: 18322037 DOI: 10.1128/MMBR.00028-07] [Cited by in Crossref: 248] [Cited by in F6Publishing: 129] [Article Influence: 17.7] [Reference Citation Analysis]
87 Mortellaro A, Robinson L, Ricciardi-Castagnoli P. Spotlight on Mycobacteria and dendritic cells: will novel targets to fight tuberculosis emerge? EMBO Mol Med 2009;1:19-29. [PMID: 20049700 DOI: 10.1002/emmm.200900008] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
88 Dao DN, Sweeney K, Hsu T, Gurcha SS, Nascimento IP, Roshevsky D, Besra GS, Chan J, Porcelli SA, Jacobs WR. Mycolic acid modification by the mmaA4 gene of M. tuberculosis modulates IL-12 production. PLoS Pathog 2008;4:e1000081. [PMID: 18535659 DOI: 10.1371/journal.ppat.1000081] [Cited by in Crossref: 75] [Cited by in F6Publishing: 72] [Article Influence: 5.4] [Reference Citation Analysis]
89 Castañeda-Delgado J, Hernández-Pando R, Serrano CJ, Aguilar-León D, León-Contreras J, Rivas-Santiago C, Méndez R, González-Curiel I, Enciso-Moreno A, Rivas-Santiago B. Kinetics and cellular sources of cathelicidin during the course of experimental latent tuberculous infection and progressive pulmonary tuberculosis. Clin Exp Immunol 2010;161:542-50. [PMID: 20636399 DOI: 10.1111/j.1365-2249.2010.04199.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.5] [Reference Citation Analysis]
90 Bar SL, Sayeh N, Ignaszewski AP. Elevated N-terminal pro-brain natriuretic peptide in Mycobacterium tuberculosis pulmonary infection without myocardial dysfunction. Can J Cardiol 2009;25:223-5. [PMID: 19340346 DOI: 10.1016/s0828-282x(09)70066-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
91 Soh AZ, Chee CBE, Wang YT, Yuan JM, Koh WP. Alcohol drinking and cigarette smoking in relation to risk of active tuberculosis: prospective cohort study. BMJ Open Respir Res 2017;4:e000247. [PMID: 29071086 DOI: 10.1136/bmjresp-2017-000247] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
92 Akhtar S, Khan A, Sohaskey CD, Jagannath C, Sarkar D. Nitrite reductase NirBD is induced and plays an important role during in vitro dormancy of Mycobacterium tuberculosis. J Bacteriol 2013;195:4592-9. [PMID: 23935045 DOI: 10.1128/JB.00698-13] [Cited by in Crossref: 32] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
93 Zhang X, Liu F, Li Q, Jia H, Pan L, Xing A, Xu S, Zhang Z. A proteomics approach to the identification of plasma biomarkers for latent tuberculosis infection. Diagn Microbiol Infect Dis 2014;79:432-7. [PMID: 24865408 DOI: 10.1016/j.diagmicrobio.2014.04.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
94 Denue BA, Kwayabura SA, Ngadda HA. Ovarian tuberculosis masquerading as ovarian cancer in HIV infected patient: a plea to avoid unnecessary surgery. Pan Afr Med J 2014;19:210. [PMID: 25829975 DOI: 10.11604/pamj.2014.19.210.5072] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
95 Konečný P, Ehrlich R, Gulumian M, Jacobs M. Immunity to the Dual Threat of Silica Exposure and Mycobacterium tuberculosis. Front Immunol 2018;9:3069. [PMID: 30687311 DOI: 10.3389/fimmu.2018.03069] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
96 Kleinwort KJH, Hauck SM, Degroote RL, Scholz AM, Hölzel C, Maertlbauer EP, Deeg C. Peripheral blood bovine lymphocytes and MAP show distinctly different proteome changes and immune pathways in host-pathogen interaction. PeerJ 2019;7:e8130. [PMID: 31788366 DOI: 10.7717/peerj.8130] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
97 Lyu L, Zhang X, Li C, Yang T, Wang J, Pan L, Jia H, Li Z, Sun Q, Yue L, Chen F, Zhang Z. Small RNA Profiles of Serum Exosomes Derived From Individuals With Latent and Active Tuberculosis. Front Microbiol 2019;10:1174. [PMID: 31191492 DOI: 10.3389/fmicb.2019.01174] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 8.3] [Reference Citation Analysis]
98 Novoa-Aponte L, León-Torres A, Patiño-Ruiz M, Cuesta-Bernal J, Salazar LM, Landsman D, Mariño-Ramírez L, Soto CY. In silico identification and characterization of the ion transport specificity for P-type ATPases in the Mycobacterium tuberculosis complex. BMC Struct Biol 2012;12:25. [PMID: 23031689 DOI: 10.1186/1472-6807-12-25] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
99 Winthrop KL. Update on tuberculosis and other opportunistic infections associated with drugs blocking tumour necrosis factor {alpha}. Ann Rheum Dis 2005;64 Suppl 4:iv29-30. [PMID: 16239382 DOI: 10.1136/ard.2005.042390] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
100 Lv L, Li C, Zhang X, Ding N, Cao T, Jia X, Wang J, Pan L, Jia H, Li Z, Zhang J, Chen F, Zhang Z. RNA Profiling Analysis of the Serum Exosomes Derived from Patients with Active and Latent Mycobacterium tuberculosis Infection. Front Microbiol 2017;8:1051. [PMID: 28659881 DOI: 10.3389/fmicb.2017.01051] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
101 Ahmad S. Pathogenesis, immunology, and diagnosis of latent Mycobacterium tuberculosis infection. Clin Dev Immunol 2011;2011:814943. [PMID: 21234341 DOI: 10.1155/2011/814943] [Cited by in Crossref: 108] [Cited by in F6Publishing: 104] [Article Influence: 9.0] [Reference Citation Analysis]
102 Díaz FE, Abarca K, Kalergis AM. An Update on Host-Pathogen Interplay and Modulation of Immune Responses during Orientia tsutsugamushi Infection. Clin Microbiol Rev 2018;31:e00076-17. [PMID: 29386235 DOI: 10.1128/CMR.00076-17] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
103 Raghunandanan S, Jose L, Gopinath V, Kumar RA. Comparative label-free lipidomic analysis of Mycobacterium tuberculosis during dormancy and reactivation. Sci Rep 2019;9:3660. [PMID: 30842473 DOI: 10.1038/s41598-019-40051-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
104 Hartman T, Weinrick B, Vilchèze C, Berney M, Tufariello J, Cook GM, Jacobs WR Jr. Succinate dehydrogenase is the regulator of respiration in Mycobacterium tuberculosis. PLoS Pathog 2014;10:e1004510. [PMID: 25412183 DOI: 10.1371/journal.ppat.1004510] [Cited by in Crossref: 63] [Cited by in F6Publishing: 47] [Article Influence: 7.9] [Reference Citation Analysis]
105 Geri G, Passeron A, Heym B, Arlet JB, Pouchot J, Capron L, Ranque B. Paradoxical reactions during treatment of tuberculosis with extrapulmonary manifestations in HIV-negative patients. Infection 2013;41:537-43. [PMID: 23203899 DOI: 10.1007/s15010-012-0376-9] [Cited by in Crossref: 40] [Cited by in F6Publishing: 32] [Article Influence: 4.0] [Reference Citation Analysis]
106 Yang K, Wu Y, Xie H, Li M, Ming S, Li L, Li M, Wu M, Gong S, Huang X. Macrophage-mediated inflammatory response decreases mycobacterial survival in mouse MSCs by augmenting NO production. Sci Rep 2016;6:27326. [PMID: 27251437 DOI: 10.1038/srep27326] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
107 Paritala H, Carroll KS. New targets and inhibitors of mycobacterial sulfur metabolism. Infect Disord Drug Targets 2013;13:85-115. [PMID: 23808874 DOI: 10.2174/18715265113139990022] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
108 Caire-Brändli I, Papadopoulos A, Malaga W, Marais D, Canaan S, Thilo L, de Chastellier C. Reversible lipid accumulation and associated division arrest of Mycobacterium avium in lipoprotein-induced foamy macrophages may resemble key events during latency and reactivation of tuberculosis. Infect Immun 2014;82:476-90. [PMID: 24478064 DOI: 10.1128/IAI.01196-13] [Cited by in Crossref: 70] [Cited by in F6Publishing: 43] [Article Influence: 7.8] [Reference Citation Analysis]
109 Brzostek A, Pawelczyk J, Rumijowska-Galewicz A, Dziadek B, Dziadek J. Mycobacterium tuberculosis is able to accumulate and utilize cholesterol. J Bacteriol 2009;191:6584-91. [PMID: 19717592 DOI: 10.1128/JB.00488-09] [Cited by in Crossref: 113] [Cited by in F6Publishing: 66] [Article Influence: 8.7] [Reference Citation Analysis]
110 Copin R, Coscollá M, Seiffert SN, Bothamley G, Sutherland J, Mbayo G, Gagneux S, Ernst JD. Sequence diversity in the pe_pgrs genes of Mycobacterium tuberculosis is independent of human T cell recognition. mBio 2014;5:e00960-13. [PMID: 24425732 DOI: 10.1128/mBio.00960-13] [Cited by in Crossref: 67] [Cited by in F6Publishing: 39] [Article Influence: 8.4] [Reference Citation Analysis]
111 Helguera-Repetto AC, Chacon-Salinas R, Cerna-Cortes JF, Rivera-Gutierrez S, Ortiz-Navarrete V, Estrada-Garcia I, Gonzalez-y-Merchand JA. Differential macrophage response to slow- and fast-growing pathogenic mycobacteria. Biomed Res Int 2014;2014:916521. [PMID: 24949482 DOI: 10.1155/2014/916521] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
112 Ilmer M, Bergauer F, Friese K, Mylonas I. Genital tuberculosis as the cause of tuboovarian abscess in an immunosuppressed patient. Infect Dis Obstet Gynecol 2009;2009:745060. [PMID: 20224814 DOI: 10.1155/2009/745060] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
113 Mirzaei R, Babakhani S, Ajorloo P, Ahmadi RH, Hosseini-Fard SR, Keyvani H, Ahmadyousefi Y, Teimoori A, Zamani F, Karampoor S, Yousefimashouf R. The emerging role of exosomal miRNAs as a diagnostic and therapeutic biomarker in Mycobacterium tuberculosis infection. Mol Med 2021;27:34. [PMID: 33794771 DOI: 10.1186/s10020-021-00296-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
114 Backus KM, Boshoff HI, Barry CS, Boutureira O, Patel MK, D'Hooge F, Lee SS, Via LE, Tahlan K, Barry CE 3rd, Davis BG. Uptake of unnatural trehalose analogs as a reporter for Mycobacterium tuberculosis. Nat Chem Biol 2011;7:228-35. [PMID: 21378984 DOI: 10.1038/nchembio.539] [Cited by in Crossref: 142] [Cited by in F6Publishing: 125] [Article Influence: 12.9] [Reference Citation Analysis]
115 Johnson DF, Malone LL, Zalwango S, Mukisa Oketcho J, Chervenak KA, Thiel B, Mayanja-Kizza H, Stein CM, Boom WH, Lancioni CL; Tuberculosis Research Unit. Tuberculin skin test reversion following isoniazid preventive therapy reflects diversity of immune response to primary Mycobacterium tuberculosis infection. PLoS One 2014;9:e96613. [PMID: 24796677 DOI: 10.1371/journal.pone.0096613] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
116 Joseph D, Tintinger GR, Ker JA, Pannell N. Adverse effects of biologic anti-inflammatory agents on the respiratory system: A review. Afr J Thorac Crit Care Med 2021;27. [PMID: 34430870 DOI: 10.7196/AJTCCM.2021.v27i2.117] [Reference Citation Analysis]
117 Newton SM, Mackie SL, Martineau AR, Wilkinson KA, Kampmann B, Fisher C, Dutta S, Levin M, Wilkinson RJ, Pasvol G. Reduction of chemokine secretion in response to mycobacteria in infliximab-treated patients. Clin Vaccine Immunol 2008;15:506-12. [PMID: 18160618 DOI: 10.1128/CVI.00401-07] [Cited by in Crossref: 21] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]